Basic Hormone Panel for a 53-Year-Old Woman
For a 53-year-old woman, order FSH, estradiol, TSH, and prolactin as the core hormone panel, with FSH and estradiol drawn during the early follicular phase (days 3-6) if she is still cycling. 1
Core Mandatory Tests
The essential hormone panel should include:
FSH (Follicle-Stimulating Hormone): Draw during early follicular phase (days 3-6) if cycles are present, or at any time if amenorrheic. An FSH >35 IU/L suggests ovarian insufficiency, though a single measurement should not be relied upon as FSH fluctuates wildly during the menopausal transition. 1, 2
Estradiol: Measure during the early follicular phase (days 3-6) if cycling. Perimenopausal women may paradoxically show hyperestrogenism despite rising FSH. Low estradiol (<30 pg/mL) confirms hypoestrogenism. 1, 3
TSH (Thyroid-Stimulating Hormone): Essential screening test as thyroid dysfunction commonly presents with menstrual irregularity and menopausal symptoms. Both hypothyroidism and hyperthyroidism can disrupt hormonal balance. 1
Prolactin: Measure morning resting levels to rule out hyperprolactinemia (>20 μg/L is abnormal), which may indicate pituitary tumor or medication effects. Never draw immediately after stress, breast examination, or sexual activity as these cause transient elevations. 1
Additional Testing Based on Clinical Context
If menstrual irregularity, hirsutism, or metabolic concerns are present, expand the panel to include:
LH (Luteinizing Hormone): An LH/FSH ratio >2 strongly suggests polycystic ovary syndrome (PCOS), while LH remains relatively normal during perimenopause as FSH rises. 1
Total Testosterone: Levels >2.5 nmol/L are abnormal and suggest PCOS or medication effect (e.g., valproate). Levels >5 nmol/L warrant referral for possible ovarian or adrenal tumor. 1
Progesterone: Measure during mid-luteal phase (3-12 days before next menses). Levels <6 nmol/L indicate anovulation, common in perimenopause. 1
Fasting glucose and lipid panel: Consider for metabolic screening, particularly if BMI >25 kg/m² or other PCOS features are present. 1
Critical Timing Considerations
Draw FSH, LH, estradiol, and testosterone between cycle days 3-6 for meaningful interpretation in women who are still cycling. 1
In amenorrheic women, these hormones can be drawn at any time. 1
Progesterone must be obtained during the expected mid-luteal phase to accurately assess ovulation. 1
Prolactin requires a single morning resting draw; avoid collection after seizures, stress, or breast stimulation. 1
Key Clinical Pitfalls to Avoid
Do not diagnose perimenopause or predict menopause timing based on a single FSH measurement. FSH levels fluctuate dramatically during the menopausal transition, and up to 40.6% of women with elevated FSH will have normal levels on subsequent testing. 1, 2
In women with prior hysterectomy but intact ovaries, serial FSH and estradiol measurements are required to confirm menopausal status, as menstrual bleeding cannot be used as a marker. 1
Menstrual history and age are more reliable indicators of menopausal status than laboratory values alone. Clinical context should guide interpretation. 1
If FSH is elevated (>35 IU/L), confirm with a repeat measurement 4 weeks later before diagnosing primary ovarian insufficiency, as two elevated values are required for diagnosis. 4
What NOT to Order Routinely
Pelvic examination, Pap smear, clinical breast examination, and HIV screening are not indicated as part of the basic hormone workup unless there are specific clinical indications beyond age and routine screening. 4
Lipid panels, fasting glucose, and liver enzymes are not part of the basic hormone panel unless metabolic concerns or PCOS features are present. 4